Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right?
Authors
Illidge, Timothy MAffiliation
Institute of Cancer Sciences, Manchester Cancer Research Centre, Manchester, UK. Electronic address: tmi@manchester.ac.ukIssue Date
2015-08
Metadata
Show full item recordCitation
Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: Have We Got the Balance Right? 2015, 27 (8):454-6 Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2015.05.007PubMed ID
26108883Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2015.05.007
Scopus Count
Collections
Related articles
- Balancing Risks in Developing a Personalised Approach to the Treatment of Early Hodgkin Lymphoma: A Haematologist's Perspective.
- Authors: Follows GA
- Issue date: 2015 Aug
- Hodgkin's disease--clinical trials and travails.
- Authors: DeVita VT Jr
- Issue date: 2003 Jun 12
- [Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
- Authors: Datsenko PV, Pan'shin GA, Sotnikov VM, Ivashin AV, Gombolevskiĭ VA, Golub SV, Evstikheev ÉV
- Issue date: 2012
- [The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
- Authors: Datsenko PV, Pan'shin GA, Sotnikov VM, Ivashin AV, Evstikheev ÉV, Golub SV, Gombolevskiĭ VA
- Issue date: 2012
- The cure of Hodgkin's disease with drugs.
- Authors: DeVita VT Jr, Hubbard SM, Moxley JH 3rd
- Issue date: 1983